Cargando…
Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
BACKGROUND AND PURPOSE: There is sufficient evidence to support vitamin D's noncalcemic effects and the role of vitamin D deficiency in the development of a wide range of neurological disorders. This study aimed to evaluate whether serum 25(OH)D and 1,25(OH) 2 D could be used as biomarkers to d...
Autores principales: | Ogura, Hiromu, Hatip-Al-Khatib, Izzettin, Suenaga, Midori, Hatip, Funda Bolukbasi, Mishima, Takayasu, Fujioka, Shinsuke, Ouma, Shinji, Matsunaga, Yoichi, Tsuboi, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477135/ https://www.ncbi.nlm.nih.gov/pubmed/34611554 http://dx.doi.org/10.1016/j.ensci.2021.100369 |
Ejemplares similares
-
Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease
por: Ouma, Shinji, et al.
Publicado: (2018) -
Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders
por: Kakimoto, Asako, et al.
Publicado: (2022) -
Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019) -
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019) -
25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)